|
Re: CTCs as prognostic and predictive factors for mbc treatments
Hmmm....The chart seems to support things I've seen in various research.
Endocrine therapy associated with least CTCs. Looks like Fulvestrant the lowest.
Traditional chemos by itself associated with highest CTCs.
Combining Traditional with alkylating agent (Carboplatin, Gemcitabine) reduces CTCs.
Herceptin (biologic) reduces CTC association a bit..Tykerb reduces it more.
Avastin seeems to reduce CTCs a bit too.
Too bad they don't test chemo + endocrine, bilogic + endocrine, chemo + endocrine + biologic or chemo combo + endocrine + biologic
|